1. Home
  2. ELTK vs ELUT Comparison

ELTK vs ELUT Comparison

Compare ELTK & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$9.20

Market Cap

53.1M

Sector

Technology

ML Signal

HOLD

ELUT

Elutia Inc.

HOLD

Current Price

$1.16

Market Cap

48.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
ELUT
Founded
1970
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
48.3M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
ELTK
ELUT
Price
$9.20
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
8.1K
144.2K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
2.14%
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
N/A
$12,293,000.00
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$0.50
52 Week High
$12.19
$2.60

Technical Indicators

Market Signals
Indicator
ELTK
ELUT
Relative Strength Index (RSI) 65.01 58.79
Support Level $8.38 $1.00
Resistance Level $9.37 $1.18
Average True Range (ATR) 0.53 0.09
MACD 0.14 0.01
Stochastic Oscillator 81.43 58.62

Price Performance

Historical Comparison
ELTK
ELUT

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: